Adjunctive aripiprazole therapy with escitalopram in patients with co-morbid major depressive disorder and alcohol dependence: Clinical and neuroimaging evidence

Journal of Psychopharmacology

Volumn 27, Issue 3, 2013, Pages 282-291

  Han, Doug Hyun ^a   Kim, Sun Mi ^a   Choi, Jung Eun ^b   Min, Kyung Joon ^a   Renshaw, Perry F ^c  

^a Chung Ang University College of Medicine   (South Korea)

^b Department of Physical Medicine and Rehabilitation   (South Korea)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

Alcohol dependence; Aripiprazole; Craving; Escitalopram; Functional magnetic resonance imaging; Major depressive disorder

Indexed keywords

ARIPIPRAZOLE; ESCITALOPRAM;

ADD ON THERAPY; ADULT; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANTERIOR CINGULATE; ARTICLE; BECK DEPRESSION INVENTORY; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL GLOBAL INDEX SEVERITY; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG DOSE INCREASE; DRUG RESPONSE; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGING SOFTWARE; KOREAN ALCOHOL URGE QUESTIONNAIRE; LEFT HEMISPHERE; MAJOR DEPRESSION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; ALCOHOL DETERRENTS; ALCOHOL DRINKING; ALCOHOLISM; ANTIPSYCHOTIC AGENTS; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; FUNCTIONAL NEUROIMAGING; GYRUS CINGULI; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEURONS; PILOT PROJECTS; PIPERAZINES; PSYCHIATRIC STATUS RATING SCALES; QUINOLONES; SEROTONIN UPTAKE INHIBITORS;

EID: 84877861048     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881112472563     Document Type: Article

References (58)

1. Asplund CA, Aaronson JW and Aaronson HE (2004) 3 regimens for alcohol withdrawal and detoxification. J Fam Pract 53: 545-554. (Pubitemid 38944175)
2. Baler RD and Volkow ND (2006) Drug addiction: The neurobiology of disrupted self-control. Trends Mol Med 12: 559-566. (Pubitemid 44780200)
3. Baumann MH, Ayestas MA, Dersch CM, et al. (2000) Effects of phentermine and fenfluramine on extracellular dopamine and serotonin in rat nucleus accumbens: Therapeutic implications. Synapse 36: 102-113. (Pubitemid 30196686)
4. Beck AT, Ward CH, Mendelson M, et al. (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
5. Beck A, Wustenberg T, Genauck A, et al. (2012) Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients. Arch Gen Psychiatry 69: 842-852.
6. Berman RM, Fava M, Thase ME, et al. (2009) Aripiprazole augmentation in major depressive disorder: a double-blind, placebo-controlled study in patients with inadequate response to antidepressants. CNS Spectr 14: 197-206.
7. Berman RM, Marcus RN, Swanink R, et al. (2007) The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 68: 843-853. (Pubitemid 47015482)
8. Bersani G, Gherardelli S, Clemente R, et al. (2005) Neurologic soft signs in schizophrenic patients treated with conventional and atypical antipsychotics. J Clin Psychopharmacol 25: 372-375. (Pubitemid 41060259)
9. Comings DE and Blum K (2000) Reward deficiency syndrome: Genetic aspects of behavioral disorders. Prog Brain Res 126: 325-341. (Pubitemid 35461297)
10. Dixon AL, Prior M, Morris PM, et al. (2005) Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48: 236-245. (Pubitemid 40208259)
11. Filbey FM, Claus E, Audette AR, et al. (2008) Exposure to the taste of alcohol elicits activation of the mesocorticolimbic neurocircuitry. Neuropsychopharmacology 33: 1391-1401. (Pubitemid 351521721)
12. Frank E and Thase ME (1999) Natural history and preventative treatment of recurrent mood disorders. Annu Rev Med 50: 453-468. (Pubitemid 29117078)
13. Grusser SM, Wrase J, Klein S, et al. (2004) Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 175: 296-302. (Pubitemid 39361918)
14. Han DH, Bolo N, Daniels MA, et al. (2011) Brain activity and desire for Internet video game play. Compr Psychiatry 52: 88-95.
15. Huang M, Ichiwaka J, Li Z, et al. (2006) Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex. Psychopharmacology (Berl) 185: 274-281.
16. Janiri L, Martinotti G and Di Nicola M (2007) Aripiprazole for relapse prevention and craving in alcohol-dependent subjects: Results from a pilot study. J Clin Psychopharmacol 27: 519-520. (Pubitemid 47415057)
17. Kalivas PW and Volkow ND (2005) The neural basis of addiction: A pathology of motivation and choice. Am J Psychiatry 162: 1403-1413. (Pubitemid 41105554)
18. Katner SN and Weiss F (2001) Neurochemical characteristics associated with ethanol preference in selected alcohol-preferring and -nonpreferring rats: A quantitative microdialysis study. Alcohol Clin Exp Res 25: 198-205. (Pubitemid 32167435)
19. Kennedy SH, Evans KR, Kruger S, et al. (2001) Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. Am J Psychiatry 158: 899-905. (Pubitemid 32547619)
20. Kessler RC, Crum RM, Warner LA, et al. (1997) Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 54: 313-321. (Pubitemid 27171916)
21. Ko CH, Liu GC, Hsiao S, et al. (2009) Brain activities associated with gaming urge of online gaming addiction. J Psychiatr Res 43: 739-747.
22. Lejoyeux M, Solomon J and Ades J (1998) Benzodiazepine treatment for alcohol-dependent patients. Alcohol Alcohol 33: 563-575. (Pubitemid 28548383)
23. Li Z, Ichikawa J, Dai J, et al. (2004) Aripiprazole, a novel antipsychotic drug, preferentially increases dopamine release in the prefrontal cortex and hippocampus in rat brain. Eur J Pharmacol 493: 75-83. (Pubitemid 38746934)
24. Liotti M and Mayberg HS (2001) The role of functional neuroimaging in the neuropsychology of depression. J Clin Exp Neuropsychol 23: 121-136. (Pubitemid 32204875)
25. Lopez JF, Akil H and Watson SJ (1999) Neural circuits mediating stress. Biol Psychiatry 46: 1461-1471.
26. Lynskey MT (1998) The comorbidity of alcohol dependence and affective disorders: Treatment implications. Drug Alcohol Depend 52: 201-209. (Pubitemid 28529578)
27. Mantere T, Tupala E, Hall H, et al. (2002) Serotonin transporter distribution and density in the cerebral cortex of alcoholic and nonalcoholic comparison subjects: A whole-hemisphere autoradiography study. Am J Psychiatry 159: 599-606. (Pubitemid 34274942)
28. Marcus RN, McQuade RD, Carson WH, et al. (2008) The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: A second multicenter, randomized, double-blind, placebo-controlled study. J Clin Psychopharmacol 28: 156-165. (Pubitemid 351417120)
29. Martinotti G, Carli V, Tedeschi D, et al. (2009a) Mono- and polysubstance dependent subjects differ on social factors, childhood trauma, personality, suicidal behaviour, and comorbid Axis I diagnoses. Addict Behav 34: 790-793.
30. Martinotti G, Di Nicola M, Di Giannantonio M, et al. (2009b) Aripiprazole in the treatment of patients with alcohol dependence: A double-blind, comparison trial vs. naltrexone. J Psychopharmacol 23: 123-129.
31. Martinotti G, Di Nicola M and Janiri L (2007) Efficacy and safety of aripiprazole in alcohol dependence. Am J Drug Alcohol Abuse 33: 393-401. (Pubitemid 47037170)
32. Martinotti G, Nicola MD, Reina D, et al. (2008) Alcohol protracted withdrawal syndrome: The role of anhedonia. Subst Use Misuse 43: 271-284. (Pubitemid 351448715)
33. Mayberg HS (2003) Modulating dysfunctional limbic-cortical circuits in depression: Towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 65: 193-207. (Pubitemid 36406467)
34. Mayberg HS, Lozano AM, Voon V, et al. (2005) Deep brain stimulation for treatment-resistant depression. Neuron 45: 651-660. (Pubitemid 40320700)
35. Myrick H, Anton RF, Li X, et al. (2004) Differential brain activity in alcoholics and social drinkers to alcohol cues: Relationship to craving. Neuropsychopharmacology 29: 393-402. (Pubitemid 38175156)
36. Nelson JC, Mankoski R, Baker RA, et al. (2010) Effects of aripiprazole adjunctive to standard antidepressant treatment on the core symptoms of depression: A post-hoc, pooled analysis of two large, placebo-controlled studies. J Affect Disord 120: 133-140.
37. Nestler EJ and Carlezon WA Jr (2006) The mesolimbic dopamine reward circuit in depression. Biol Psychiatry 59: 1151-1159. (Pubitemid 44192421)
38. Nishikawa M, Diksic M, Sakai Y, et al. (2009) Alterations in brain serotonin synthesis in male alcoholics measured using positron emission tomography. Alcohol Clin Exp Res 33: 233-239.
39. Ostacher MJ (2007) Comorbid alcohol and substance abuse dependence in depression: Impact on the outcome of antidepressant treatment. Psychiatr Clin North Am 30: 69-76. (Pubitemid 46386306)
40. Paterson NE and Markou A (2007) Animal models and treatments for addiction and depression co-morbidity. Neurotox Res 11: 1-32.
41. Regier DA, Farmer ME, Rae DS, et al. (1990) Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 264: 2511-2518.
42. Rosa-Neto P, Diksic M, Okazawa H, et al. (2004) Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression. Arch Gen Psychiatry 61: 556-563. (Pubitemid 38747310)
43. Ross S and Peselow E (2009) The neurobiology of addictive disorders. Clin Neuropharmacol 32: 269-276.
44. Schlagenhauf F, Dinges M, Beck A, et al. (2010) Switching schizophrenia patients from typical neuroleptics to aripiprazole: Effects on working memory dependent functional activation. Schizophr Res 118: 189-200.
45. Sheffrin M, Driscoll HC, Lenze EJ, et al. (2009) Pilot study of augmentation with aripiprazole for incomplete response in late-life depression: Getting to remission. J Clin Psychiatry 70: 208-213.
46. Smith AD and Weiss F (1999) Ethanol exposure differentially alters central monoamine neurotransmission in alcohol-preferring versus -nonpreferring rats. J Pharmacol Exp Ther 288: 1223-1228. (Pubitemid 29254162)
47. Snyder JL and Bowers TG (2008) The efficacy of acamprosate and naltrexone in the treatment of alcohol dependence: A relative benefits analysis of randomized controlled trials. Am J Drug Alcohol Abuse 34: 449-461. (Pubitemid 351913745)
48. Stein DJ (2008) Depression, anhedonia, and psychomotor symptoms: The role of dopaminergic neurocircuitry. CNS Spectr 13: 561-565.
49. Storvik M, Tiihonen J, Haukijarvi T, et al. (2006) Lower serotonin transporter binding in caudate in alcoholics. Synapse 59: 144-151. (Pubitemid 43121918)
50. Storvik M, Tiihonen J, Haukijarvi T, et al. (2007) Amygdala serotonin transporters in alcoholics measured by whole hemisphere autoradiography. Synapse 61: 629-636. (Pubitemid 46934010)
51. Talairach J and Tournoux P (1988) Co-planar Stereotactic Atlas of the Human Brain. New York: Thieme Medical Publishers, Inc.
52. Taneja C, Papakostas GI, Jing Y, et al. (2012) Cost-effectiveness of adjunctive therapy with atypical antipsychotics for acute treatment of major depressive disorder. Ann Pharmacother 46: 642-649.
53. Tapert SF, Brown GG, Baratta MV, et al. (2004) fMRI BOLD response to alcohol stimuli in alcohol dependent young women. Addict Behav 29: 33-50. (Pubitemid 37518226)
54. Tremblay LK, Naranjo CA, Graham SJ, et al. (2005) Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe. Arch Gen Psychiatry 62: 1228-1236. (Pubitemid 41586922)
55. Vergne DE and Anton RF (2010) Aripiprazole: A drug with a novel mechanism of action and possible efficacy for alcohol dependence. CNS Neurol Disord Drug Targets 9: 50-54.
56. Vohora D (2007) Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia. Curr Opin Investig Drugs 8: 531-538. (Pubitemid 47016321)
57. Voronin K, Randall P, Myrick H, et al. (2008) Aripiprazole effects on alcohol consumption and subjective reports in a clinical laboratory paradigm - possible influence of self-control. Alcohol Clin Exp Res 32: 1954-1961.
58. Weisler RH, Khan A, Trivedi MH, et al. (2011) Analysis of suicidality in pooled data from 2 double-blind, placebo-controlled aripiprazole adjunctive therapy trials in major depressive disorder. J Clin Psychiatry 72: 548-555.